Exercise training-induced benefits for Alzheimer’s disease are associated with modulation of the BDNF-TrkB signaling complex Authors: Taewan Kim, Jinkyung Cho, Hyunsik Kang Published: 2025 ABSTRACT The mechanism(s) by which exercise training induces multiple beneficial effects for Alzheimer’s disease (AD) patients are not well-understood. This study aimed to examine the link between the brain-derived neurotrophic factor (BNDF)-tropomyosin receptor kinase B (TrkB) signaling complex and the beneficial effects of exercise training on cognitive impairment and neuropathology due to AD. At 4 months of age, twenty triple transgenic mice of AD (3x-Tg AD) were randomly assigned to either an AD control (n = 10) or AD exercise (n = 10) group. In parallel, twenty wild-type mice were randomly assigned to either a wild-type control (n = 10) or wild-type exercise (n = 10) group. After 20 weeks of treadmill running, the Morris water maze test was performed, and the mice were then sacrificed for biochemical analyses of plasma and brain tissues. The results indicated that 20 weeks of treadmill running upregulated markers of the BDNF-TrkB signaling complex and mitigated AD neuropathology, along with full recovery from AD-like cognitive impairments. Exercise training also decreased inflammatory cytokines, increased anti-inflammatory cytokines, shifted microglia and astrocytes toward anti-inflammatory phenotypes, improved mitochondrial function, reduced markers of myelin damage, and reduced apoptotic neuronal cell death. In summary, our study findings suggest that exercise training-induced recovery of AD-like cognitive impairments and mitigation of AD neuropathologic biomarkers are associated with modulation of the BDNF-TrkB complex and downstream signaling pathways in 3xTg-AD mice.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-025-33262-6. Introduction Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by excessive accumulation of amyloid plaques in brain cells and tau protein tangles outside the cells. The pathological hallmarks of AD include impaired brain function and cell death in affected regions of the brain, leading to memory loss and cognitive impairment. Amyloid plaques and neurofibrillary tangles are involved in the progression of this disease through neuroinflammation. Glial cells, including astrocytes and microglia, play a crucial role in neuroinflammation by inducing inflammatory responses. Although this glial cell-mediated immune response can initially help clear amyloid plaques and maintain brain homeostasis, it can also become chronic, contributing to neuronal damage or loss. This sustained immune response in the brain is another key pathology of AD1. Although no approved disease-modifying medications are available for patients with AD2, an active lifestyle, with physical activity as a key component, is considered an alternative to help prevent or delay disease3. Increased physical exercise is associated with a lower risk of AD, better cognitive performance, and reduced cognitive decline. However, the exact mechanisms underlying exercise-induced benefits for AD remain unknown. Understanding the mechanisms could lead to the development of a better treatment strategy for AD. Previous studies indicated that physical exercise promotes neurogenesis, enhances cognitive function, and offers neuroprotection through the brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B (TrkB) complex. This complex activates the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway, the phosphoinositide 3-kinase (PI3K)-protein kinase B (Akt) pathway, and the phosphoinositide phospholipase Cγ pathway. Exercise training-induced activation of the PI3K-Akt pathway and its downstream targets is essential for neuronal survival4, growth5, and synaptic plasticity6. This activation also results in anti-inflammatory, antioxidant, and anti-apoptotic effects7, as well as the promotion of remyelination8 and mitochondrial function9. Additionally, the NF-κB-Bax-Bcl-2/caspase and PGC1α-Nrf2 pathways are essential for managing cellular stress, inflammation, and apoptosis. NF-κB functions as a major transcription factor in inflammation, whereas Bax, Bcl-2, and caspases are involved in the intrinsic apoptotic pathway. PGC1α and Nrf2 are vital for maintaining metabolic balance and protecting cells from oxidative stress. Physical exercise enhances neuronal communication, protects the brain, creates new brain cells, keeps nerve cells alive, and supports mitochondrial function by activating these pathways individually or collectively, leading to delayed progression of AD and better cognitive performance. This study aimed to investigate the relationship between the BDNF-TrkB signaling pathway and its role in facilitating the beneficial effects of exercise training for AD concerning neuropathology, neuroinflammation, glial cells, myelination, mitochondrial function, and neuronal cell death. Methods Animals and experimental design Twenty 4-month-old triple transgenic (3xTg-AD) male mice carrying the APPSwe, PS1M146V, and tauP301L transgenes were purchased from Jackson Laboratory (New Harbor, ME, USA). Twenty 4-month-old wild-type (WT) male mice (B6129SF2J) were obtained from Orient Bio (Seongnam, Republic of Korea). The mice were housed and maintained at 22 ± 2 °C under a 12:12-h light/dark cycle in pathogen-free conditions. All animal experimental procedures were approved by the Sungkyunkwan University School of Medicine Institutional Animal Care and Use Committee (SKKUIACUC2022-07-24-1) and were performed in accordance with the relevant guidelines and regulations. The study was conducted and reported in accordance with the ARRIVE guidelines. As shown in Fig. 1, AD mice were randomly assigned to control (AD, n = 10) or exercise (ADEX, n = 10) groups, and WT mice were randomly assigned to control (WT, n = 10) or exercise (WTEX, n = 10) groups. ADEX and WTEX mice were subjected to 20 weeks of treadmill running, whereas AD and WT mice remained in their cages. The Morris water maze (MWM) test was conducted in week 19, after which the mice were anesthetized with a combination of tiletamine hydrochloride and zolazepam as well as xylazine before being euthanatized at week 20. After blood collection from the tail vein, the mice were transcardially perfused with 1x phosphate-buffered saline (PBS), and their brains were extracted. For immunohistochemistry, the brains were fixed in 4% paraformaldehyde and then incubated in 30% sucrose at 4 °C. The remaining brains were flash-frozen in liquid nitrogen and stored at -80 °C until immunoblotting analysis. Fig. 1Experimental design. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. Experimental design. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. Exercise training and MWM After a 2-day acclimatization period of 10 min each (first day at 5 m/min; second day at 8 m/min), the mice assigned to the exercise groups underwent 20 weeks of running on a motor-driven animal treadmill (Columbus Instruments, Inc., Columbus, OH, USA), with a duration of 30 min per session and frequency of 5 days per week. Each treadmill session started with a 5-min warm-up at 5 m/min, followed by 5 min at 8 m/min, and then 20 min at a maximum speed of 11 m/min. To prevent physiological adaptation, the maximum speed was increased by 1 m/min every month until it reached 15 m/min. Electric shock was not used to minimize stress. A modified version of the MWM test was used to evaluate spatial learning and memory. The MWM test was performed in a circular pool with a diameter of 120 cm, with the water kept at a temperature of 22–23℃. A translucent acrylic escape platform was consistently positioned in the southeast quadrant. The pool was filled with water to 1 cm above the escape platform, and four distinct visual cues (triangle, square, circle, and star) were placed on the surrounding walls at 0°, 90°, 180°, and 270°, corresponding to the four quadrants of the maze. A camera mounted above the pool recorded swimming behavior during the test. These recordings were analyzed using Ethovision XT software (Nodulus Information Technologies, Leesburg, VA, USA). The variables measured in the MWM included escape latency (time taken by the mouse to reach the escape platform in seconds), number of platform crossings (number of times the mouse crossed over the escape platform), total time spent in the target quadrant, and cumulative time in the quadrant containing the escape platform. The acquisition task consisted of three trial sessions per day for four consecutive days, with each session separated by 30 min. In each trial, the mice were gently released from one of four randomly assigned starting points (east, west, north, or south) and allowed to swim until they reached the escape platform. Mice that did not find the platform within 60 s were placed on it for 20 s, which was the same duration as the successful animals. The next day, the mice were subjected to a 24-h long-term memory retention test in which the platform was removed from the maze, and the mice were allowed to swim for 1 min. Biochemical assay Plasma levels of cytokines were assessed using commercially available enzyme-linked immunosorbent assay (ELISA) kits from Thermo Fisher Scientific (Waltham, MA, USA): TNF alpha mouse (BMS607-3), IL-6 mouse (KMC0061), IL-12 mouse (BMS616), IL-10 mouse (BMS614), IL-4 mouse (BMS613), and TGF beta-1 mouse (BMS608-4) ELISA kits. Western blot Protein extracts from the hippocampal and cortical tissues were prepared by homogenization. The homogenates were centrifuged, and the protein concentrations of the supernatants were determined using the Bradford assay (Bio-Rad, Hercules, CA, USA). Western blotting was performed as previously described10,11. Finally, blots were developed using a chemiluminescent horseradish peroxidase substrate kit (Millipore, Billerica, MA, USA), and the band intensity was quantified using ImageJ version 1.42 software (National Institutes of Health, Bethesda, MD, USA) and normalized against β-actin densitometric values. Immunohistochemistry and Immunofluorescence Fixed brains were sliced into 40 μm-thick sections using a microtome (CM3050S; Leica Microsystems, Wetzlar, Germany) and then placed in cold cryoprotectant solution (80 mM K2HPO4, 20 mM KH2PO4, 154 mM NaCl, 0.3 g/mL sucrose, 0.01 g/mL polyvinylpyrrolidone, 30% v/v ethylene glycol). Brain sections were treated with 1% H2O2 in PBS (pH 7.5) to block endogenous peroxidase activity. The sections were washed with PBS and blocked for 1 h with 0.3% Triton X-100 and 3% normal goat serum in PBS. Following overnight incubation at 4 °C with mouse anti-amyloid antibody (6E10; 803015, BioLegend, San Diego, CA, USA), the sections were washed in PBS. The sections were then incubated at room temperature for 1 h with biotinylated goat anti-mouse IgG antibodies (Ba-9200; Vector Laboratories, Burlingame, CA, USA) and washed with PBS. Sections were incubated for 1 h with biotinylated goat anti-mouse IgG antibodies (BA-1000; Vector Laboratories, Burlingame, CA, USA) in Avidin-Biotin Complex solution (Vector Laboratories) and diaminobenzidine for 2–5 min. After three washes with PBS, the sections were mounted onto gelatin-coated glass slides and air-dried overnight. The sections were then dehydrated in ethanol, cleared in xylene, and mounted with Eukitt® Quick-hardening mounting medium (03989; Sigma-Aldrich, St. Louis, MO, USA) under coverslips. For immunofluorescence analysis, the brain sections were blocked with 3% normal goat serum (Gibco, Grand Island, NY, USA) and then incubated overnight at 4 °C with primary antibodies (Supplement 1). The sections were subsequently washed with PBS and incubated with secondary antibodies for 2 h (Supplement 2). DNA was stained with DAPI (Santa Cruz Biotechnology, Dallas, TX, USA) before mounting the sections onto glass slides. A specialist blinded to the experimental protocol examined the stained brain sections. Images were captured using a Zeiss LSM 510 META Duoscan confocal microscope (Zeiss, Oberkochen, Germany) equipped with a 20× objective lens. After image acquisition, cells were counted using ImageJ software (National Institutes of Health, Bethesda, MD, USA) to determine the number of positive cells per defined area. Flow cytometry analysis Mouse brains were harvested for quantification of microglia and astrocytes in the hippocampus. Cell markers including anti-CD45 (30-F11; eBioscience, San Diego, CA, USA) and anti-GLAST (130-118-483; Miltenyi Biotec, Bergisch Gladbach, Germany) were used to label live microglia and astrocytes. The labeled cells were analyzed using a FACSCanto II flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA), and the resulting data were processed using FlowJo 7.6.5 software (TreeStar, Ashland, OR, USA). TUNEL assay A terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed on brain tissue sections. The sections were first permeabilized with Triton X-100 for 2 min at 4 °C, and then incubated in TUNEL reagent for 60 min at 37 °C. Stained slides were subjected to morphological analysis using a Leica QWin Image Analyzer System in combination with a Leica DMLS microscope (Leica Microsystems). After capturing the images, cells were manually counted to determine the number of TUNEL-positive cells per defined area. TUNEL-positive cells were defined as cells exhibiting a TUNEL signal. All image analyses were performed by a blinded investigator to ensure unbiased quantification. High-resolution respirometry The hippocampal tissues were homogenized in assay buffer (buffer Z with 50 µmol/L EGTA and 20 mmol/L creatine) and then placed in a high-resolution polarographic respirometer chamber equipped with an Oxygraph-2k (OROBOROS, Innsbruck, Austria). To measure electron flow through complex I, a substrate mixture of 5 mmol/L pyruvate and 2 mmol/L malate was used to assess the leak oxygen consumption. After stabilization, 4 mM adenosine diphosphate (ADP) was added to evaluate the oxidative capacity, followed by the addition of 10 mM succinate to measure electron flow through complex II. Mitochondrial O₂ respiration levels were normalized to the lung tissue weight. Statistical analysis The results are presented as the means ± standard deviation. Two-way analysis of variance was used to detect significant interactions between time and group with average escape latency. If Mauchly’s sphericity test found a violation, Greenhouse-Geisser adjustment was used to adjust the degrees of freedom accordingly. One-way analysis of variance and the least significant difference method were used to test group differences in outcomes among WT, WTEX, AD, and ADEX mice, followed by post-hoc multiple comparisons, if necessary. Statistical significance was set at p = 0.050. All statistical analyses were conducted using SPSS-PC software (version 21.0, SPSS, Inc., Chicago, IL, USA). Results Exercise training modulates the BDNF-TrkB signaling complex and mitigates amyloid beta and Tau pathology AD mice exhibited significantly lower levels of BDNF, p-Akt/Akt, and PGC-1α but higher levels of p-PI3K/PI3K, p-GSK3β/GSK3β, and NF-κB in the hippocampus, as compared to those in WT mice. In contrast, ADEX mice exhibited higher levels of BDNF, p-TrkB, p-PI3K/PI3K, p-AKT/AKT, p-GSK3β/GSK3β, PGC-1α, and FNDC5 but lower levels of p-NF-κB in the hippocampus as compared to those in AD mice (Fig. 2A). Similarly, WTEX mice exhibited significantly higher levels of BDNF, p-TrkB, p-PI3K/PI3K, p-Akt/Akt, p-GSK3β/GSKβ, and FNDC5 than those in WT mice. Our study findings indicate that 20 weeks of treadmill running modulated the BDNF-TrkB-PI3K-Akt signaling pathway and its downstream targets in 3x-Tg AD mice, including GSK3, PGC-1, FNDC5, and NF-κB. Fig. 2Responses of the BDNF/TrkB signaling pathways and Aβ and tau hyperphosphorylation to 20 weeks of treadmill running. (A) Western blot analysis and quantification of BDNF, TrkB, p-TrkB, PI3K p85, p-PI3K p85, AKT, p-AKT, GSK3β, p-GSK3β, PGC-1α, FNDC5, NF-κB, and p-NF-κB. (B) Western blot analysis and quantification of APP, Aβ, and phosphorylated tau (p-tau 205/tau 46, p-tau 396/tau 46) in the hippocampus. (C) Immunohistochemical staining of Aβ plaque burden in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of the BDNF/TrkB signaling pathways and Aβ and tau hyperphosphorylation to 20 weeks of treadmill running. (A) Western blot analysis and quantification of BDNF, TrkB, p-TrkB, PI3K p85, p-PI3K p85, AKT, p-AKT, GSK3β, p-GSK3β, PGC-1α, FNDC5, NF-κB, and p-NF-κB. (B) Western blot analysis and quantification of APP, Aβ, and phosphorylated tau (p-tau 205/tau 46, p-tau 396/tau 46) in the hippocampus. (C) Immunohistochemical staining of Aβ plaque burden in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. As expected, AD mice exhibited higher levels of APP, Aβ, p-tau205/tau 46, and p-tau 396/tau 46 proteins in the hippocampus in conjunction with a greater Aβ plaque count in the hippocampal CA1 and CA3 regions compared to those in WT mice. In contrast, ADEX mice exhibited lower levels of hallmark proteins of AD pathology in the affected brain regions compared with those in AD mice (Fig. 2B, C). Our findings indicate that 20 weeks of treadmill running mitigated the AD-induced amyloid burden and neurofibrillary tangles in 3x-Tg AD mice. Exercise training reduces inflammatory responses and promotes anti-inflammatory responses AD mice exhibited higher levels of TNF-α, IL-6, and IL-12 in the blood and higher levels of NLRP3 and TNF-α in the hippocampus, but lower blood TGF-β and hippocampal IL-10 and TGF-β levels, as compared to WT mice. In contrast, ADEX mice exhibited lower levels of IL-6 and IL-12 in the blood, higher levels of IL-4, IL-10, and TGF-β in the blood, and lower hippocampal levels of TNF-α but higher hippocampal levels of IL-4, IL-10, and TGF-β, as compared to AD mice (Fig. 3A, B). Fig. 3Responses of inflammatory cytokines to 20 weeks of treadmill running. (A) ELISA analysis of pro- and anti-inflammatory cytokines in blood (TNF-α, IL-6, IL-12, IL-4, IL-10, TGF-β) and (B) western blot analysis of hippocampal inflammatory markers (NLRP3, TNF-α, IL-4, IL-10, TGF-β). Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of inflammatory cytokines to 20 weeks of treadmill running. (A) ELISA analysis of pro- and anti-inflammatory cytokines in blood (TNF-α, IL-6, IL-12, IL-4, IL-10, TGF-β) and (B) western blot analysis of hippocampal inflammatory markers (NLRP3, TNF-α, IL-4, IL-10, TGF-β). Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. AD mice exhibit lower levels of hippocampal TREM2 compared with those in WT mice. In contrast, compared with AD mice, ADEX mice had higher levels of hippocampal CD200, CD200R, and TREM2 (Fig. 4A). Flow cytometry showed that AD mice exhibited lower total microglia and higher activated microglia than did WT mice. Immunofluorescence staining showed that compared with WT mice, AD mice exhibited a larger CD86 + area in the hippocampal CA1 region and a smaller CD206 + area in the hippocampal CA1 and CA3 regions. In contrast, ADEX mice exhibited a smaller CD86 + area than did AD mice (Fig. 4B). Flow cytometry also showed that AD mice had fewer total and activated astrocytes than did WT mice. However, these tendencies were reversed after 20 weeks of treadmill running, as shown in ADEX vs. AD mice. Immunofluorescence staining revealed that AD mice exhibited a shift in the astrocyte phenotype toward an inflammatory state with an increase in the A1 phenotype and a decrease in the A2 phenotype in the affected regions of the brain, as compared to the results in WT mice. This shift in astrocyte phenotype was reversed after 20 weeks of treadmill running, as observed in ADEX vs. AD mice (Fig. 4C). Overall, our findings for the cytokines, immunoglobulins, and glial cells suggest that 20 weeks of treadmill running exerted a dual effect on inflammation, reducing pro-inflammatory responses while promoting anti-inflammatory responses in 3x-Tg AD mice. Fig. 4Responses of immune cells to 20 weeks of treadmill running. (A) Western blot analysis and quantification of hippocampal microglial regulatory markers (TREM2, CD200, CD200R). (B) Flow cytometry and immunofluorescence staining of microglial populations. Representative images show CD86+ (pro-inflammatory) and CD206+ (anti-inflammatory) microglia in the hippocampal CA1 and CA3 regions. (C) Flow cytometry and immunofluorescence staining of astrocytic populations. Representative images show A1 (neurotoxic) and A2 (neuroprotective) astrocyte phenotypes in hippocampal regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of immune cells to 20 weeks of treadmill running. (A) Western blot analysis and quantification of hippocampal microglial regulatory markers (TREM2, CD200, CD200R). (B) Flow cytometry and immunofluorescence staining of microglial populations. Representative images show CD86+ (pro-inflammatory) and CD206+ (anti-inflammatory) microglia in the hippocampal CA1 and CA3 regions. (C) Flow cytometry and immunofluorescence staining of astrocytic populations. Representative images show A1 (neurotoxic) and A2 (neuroprotective) astrocyte phenotypes in hippocampal regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Exercise training mitigates AD-related mitochondrial dysfunction Analysis of mitochondrial function markers showed that compared with AD mice, ADEX mice exhibited lower levels of PM, ADP, and succinate but higher levels of DAC, complex II, complex III, complex IV, and complex V in the hippocampus. AD mice exhibited lower levels of VDAC, complex I, complex IV, and complex V in the hippocampus than the levels in WT mice (Fig. 5A, B). Analysis of mitophagy and mitochondrial dynamics-related biomarkers showed that AD mice exhibited higher levels of 4-HNE, SOD2, Parkin, and LC3 but lower catalase levels in the hippocampus compared with those in WT mice. In contrast, compared with AD mice, ADEX mice exhibited higher expression levels of catalase, GPX1, SOD2, Parkin, and LC3 in the hippocampus (Fig. 5C). Examination of mitochondrial transfer markers revealed that AD mice exhibited lower Miro 1, Miro 2, and F-actin levels in the hippocampus, as well as lower Miro 1 fluorescence intensity in the hippocampal CA3 region compared with the levels in WT mice. In contrast, ADEX mice exhibited higher Miro 1 and Miro 2 levels in the hippocampus but higher Miro 1 fluorescence intensity in the CA1 and CA3 regions compared with the levels in AD mice (Fig. 5D, E). Collectively, our findings suggest that 20 weeks of treadmill running mitigates AD-related impairments in mitophagy, mitochondrial biogenesis, and mitochondrial transfer in 3x-Tg AD mice. Fig. 5Responses of hippocampal mitochondrial function markers to 20 weeks of treadmill running. (A) Measurement of mitochondrial respiratory substrates (PM, ADP, succinate) and (B) Western blot analysis of mitochondrial biogenesis markers (VDAC, complex I–V) in the hippocampus. (C) Western blot analysis of mitophagy and mitochondrial dynamics-related markers (4-HNE, SOD2, Parkin, LC3, catalase, GPX1) in the hippocampus. (D) Western blot analysis of mitochondrial transfer markers (Miro 1, Miro 2, F-actin) and (E) Immunofluorescence staining of a mitochondrial transfer marker (Miro 1) in the hippocampus. Representative images show Miro 1 fluorescence intensity in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of hippocampal mitochondrial function markers to 20 weeks of treadmill running. (A) Measurement of mitochondrial respiratory substrates (PM, ADP, succinate) and (B) Western blot analysis of mitochondrial biogenesis markers (VDAC, complex I–V) in the hippocampus. (C) Western blot analysis of mitophagy and mitochondrial dynamics-related markers (4-HNE, SOD2, Parkin, LC3, catalase, GPX1) in the hippocampus. (D) Western blot analysis of mitochondrial transfer markers (Miro 1, Miro 2, F-actin) and (E) Immunofluorescence staining of a mitochondrial transfer marker (Miro 1) in the hippocampus. Representative images show Miro 1 fluorescence intensity in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Exercise training mitigates AD-related Myelin damage and neuronal cell death AD mice exhibited lower NG2 levels but higher PLP levels in the hippocampus than WT mice. Immunofluorescence staining also showed that AD mice exhibited lower NG2 and BMP levels in the hippocampal CA1 region compared with the levels in WT mice. In contrast, ADEX mice exhibited higher NG2 and BMP but lower PLP levels in the hippocampus than did AD mice. Immunofluorescence staining also showed that ADEX mice exhibited higher BMP levels in the CA1 and CA3 regions compared with the levels in AD mice (Fig. 6A, B). Fig. 6Responses of myelin damage and apoptotic markers to 20 weeks of treadmill running. (A) Western blot analysis and (B) immunofluorescence staining of hippocampal myelin/oligodendrocyte markers (NG2, PLP, MBP) in the hippocampus. Representative images show NG2 and MBP fluorescence intensity in the CA1 and CA3 regions. (C) TUNEL staining and (D) western blot analysis of apoptosis-related proteins (NF-κB, p-NF-κB, Bax, caspase-9, caspase-3, cleaved caspase-3, BCL-2) in the hippocampus. Representative images show TUNEL-positive cells in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of myelin damage and apoptotic markers to 20 weeks of treadmill running. (A) Western blot analysis and (B) immunofluorescence staining of hippocampal myelin/oligodendrocyte markers (NG2, PLP, MBP) in the hippocampus. Representative images show NG2 and MBP fluorescence intensity in the CA1 and CA3 regions. (C) TUNEL staining and (D) western blot analysis of apoptosis-related proteins (NF-κB, p-NF-κB, Bax, caspase-9, caspase-3, cleaved caspase-3, BCL-2) in the hippocampus. Representative images show TUNEL-positive cells in the CA1 and CA3 regions. Scale bar = 40 μm. Cropped blots are shown, and proteins detected on different gels are separated by dividing lines. Cropped, unprocessed blots are provided in the Supplementary Information. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. AD mice exhibited higher TUNEL-positive cells in the hippocampal CA1 and CA3 regions, along with higher hippocampal NF-κB, p-NF-κB, and Bax, but lower caspase-9 and caspase-3 proteins, as compared with those in WT mice. In contrast, ADEX mice had lower TUNEL-positive cells in the affected regions, along with lower levels of p-NF-κB, caspase-3, Bax, and cleaved caspase-3, but higher levels of caspase-9 and BCL-2, as compared with those in AD mice (Fig. 6C, D). Collectively, our findings indicate that 20 weeks of treadmill running mitigated AD-related myelin damage and apoptosis in 3x-Tg AD mice. Exercise training recovers AD-related cognitive impairments As shown in Fig. 7, the MWM-based cognitive performance test showed a significant time-by-group interaction (F (5.805, 69.662) = 2.742, p = 0.020). AD mice had the longest average escape latency during the four-day trial period, with no significant differences among the other groups (Fig. 7A). AD mice spent less time in the target quadrant during probe trials in the long-term memory performance test than did WT mice (p = 0.030). In contrast, ADEX mice spent more time in the target quadrant and had more platform crossings than did WT (p = 0.011 and p = 0.025, respectively) and AD mice (p < 0.001 and p = 0.002, respectively) (Fig. 7B, C). Taken together, our findings suggest that 20 weeks of treadmill running resulted in full recovery from AD-related cognitive impairment in 3x-Tg AD mice. Fig. 7Responses of Morris water maze (MWM) test-based spatial learning and memory performance to 20 weeks of treadmill running. (A) Escape latency patterns. (B) Time spent in the target quadrant and (C) number of platform crossings during probe trials for long-term memory. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Responses of Morris water maze (MWM) test-based spatial learning and memory performance to 20 weeks of treadmill running. (A) Escape latency patterns. (B) Time spent in the target quadrant and (C) number of platform crossings during probe trials for long-term memory. Data are expressed as the mean ± SEM. WT: wild-type control; WTEX: wild-type exercise; AD: Alzheimer’s disease control; ADEX: Alzheimer’s disease exercise. *p < 0.050. Discussion We investigated the beneficial effects of physical exercise on AD neuropathology in 3x-Tg AD mice, focusing on Aβ and tau protein biomarkers, inflammation, mitochondrial function, myelination, and apoptosis. Our findings indicate that 20 weeks of treadmill running mitigated disease progression through several factors involved in neuropathology and resulted in full recovery from cognitive impairment in AD mice. Furthermore, our findings suggest that the beneficial effects of exercise training on AD neuropathology are related to modulation of the BDNF-TrkB-PI3K-Akt pathway and its downstream targets. Exercise training mitigates AD-like cognitive impairments and Aβ and tau pathology by modulating the BDNF-TrkB signaling complex Physical exercise increases hippocampal BDNF production, promotes BDNF-TrkB binding, and activates its downstream signaling targets, including the PI3K-Akt pathway, the MAPK-Ras-ERK pathway, and the PLC-γ-PKC pathway12. These signaling pathways are involved in regulating neuronal survival, promoting neuronal differentiation, and enhancing synaptic plasticity13. Additionally, these pathways play crucial roles in neuronal survival and plasticity, apoptosis inhibition, and cell growth promotion13. Regarding Aβ and tau pathology, our findings indicate that exercise training-induced mitigations of amyloid plaques and tau protein tangles are linked to inactivation of GSK3β, perhaps via an upregulation of the BDNF-TrkB-PI3K-Akt pathway. For example, exercise-induced upregulation of BDNF activates Akt, which phosphorylates GSK3β at Ser9 and thereby inhibits GSK3β activity. The inhibition of GSK3β results in a reduction of APP phosphorylation and a reduction of BACE1-induced Aβ production14. Additionally, this BDNF-Akt-induced inhibition of GSK3β also plays a role in suppressing tau hyperphosphorylation15. In support of our findings, previous experimental studies involving AD rodent models provided substantial evidence supporting the BDNF-TrkB-PI3K-Akt pathway as a mechanism by which it mitigates aspects of AD pathology12,16–18. Concerning AD-like cognitive impairment, our results correspond with prior research indicating that exercise training enhances cognitive function in AD, with BDNF serving as a principal mediator19,20. Moreover, our study suggests that exercise training may confer neuroprotective effects in AD by enhancing the BDNF-TrkB signaling pathway, thereby affecting inflammatory responses, myelination, mitochondrial function, and neuronal cell death13,14,21. Previous studies also demonstrated that exercise training enhanced hippocampal BDNF production through the PGC-1α-FNDC5 pathway, which is crucial for neuronal survival and synaptic plasticity22. The results from both current and prior studies indicate that exercise training alleviates Aβ and tau pathology, perhaps via the BDNF-TrkB signaling pathway. Our results correspond with prior research indicating that exercise training enhances cognitive function in AD, with BDNF serving as a principal mediator19,20. Moreover, our study suggests that exercise training may confer neuroprotective effects in AD by enhancing the BDNF-TrkB signaling pathway, thereby affecting inflammatory responses, myelination, mitochondrial function, and neuronal cell death13,14,21. A prior study demonstrated that exercise training enhanced hippocampal BDNF production through the PGC-1α-FNDC5 pathway, which is crucial for neuronal survival and synaptic plasticity22. The results from both current and prior studies indicate that exercise training alleviates Aβ and tau pathology. It suggests that the BDNF-TrkB signaling pathway may play a critical role in facilitating these beneficial effects. Exercise training mitigates mitochondrial dysfunction and Myelin damage associated with AD Mitochondrial dysfunction in neurons is implicated in the progression of AD by disrupting the energy supply for myelin synthesis and maintenance by oligodendrocytes, which are responsible for the generation of myelin. Our study indicates that 20 weeks of treadmill running mitigated AD-induced impairments in mitophagy, mitochondrial biogenesis, and mitochondrial transfer, potentially improving mitochondrial function. Our findings align with previous studies of rodent AD models, which report that exercise training enhances mitochondrial structure, increases ATP production, and boosts synaptic density. Mechanistically, physical exercise activates PGC-1α–dependent pathways, which promote mitochondrial biogenesis, regulate mitochondrial dynamics (MFN1/2-mediated fusion and DRP1-mediated fission), and stimulate PINK1-Parkin-dependent mitophagy, thereby contributing to mitochondrial health and function in AD23–25. Nonetheless, further study is guaranteed to determine the mechanisms by which physical exercise mitigates AD-related mitochondrial dysfunction at the cellular and molecular levels. Additionally, our findings suggest that exercise training mitigates AD-related myelin damage and neuronal cell death. These findings are consistent with those of recent studies using rodent models of AD and clinical studies demonstrating the suppressive or protective effects of exercise training against demyelination and/or neuronal cell death19,20. Exercise training promotes remyelination by activating BDNF-TrkB signaling, which enhances oligodendrocyte progenitor cell proliferation and maturation while simultaneously reducing microglial pro-inflammatory activity and enhancing astrocyte-mediated metabolic support, thereby creating a myelin-repairing environment under AD-related pathological conditions21–23. Exercise training mitigates neuroinflammation and neuronal cell death associated with AD Regarding the interplay between cytokines and immune cells, our findings suggest that exercise can modulate immune system responses, reduce harmful inflammatory responses, and simultaneously promote beneficial anti-inflammatory reactions. In agreement with our findings, previous studies indicated that exercise can modulate glial cell activity, potentially mitigating an inflammatory response through the BDNF-TrkB signaling complex12,24. Physical exercise can also induce a shift in the glial cell phenotype in the central nervous system, favoring neuroprotection and neuroplasticity25. Specifically, exercise can shift microglia towards a more neuroprotective state, reduce their chronic activation, and improve their ability to prune synapses26. Exercise training also enhances astrocyte function, promotes synaptic support, and reduces neuroinflammation26. A recent study using single-nucleus RNA sequencing examined how free-wheel running shapes the neurogenic stem cell niche in the dentate gyrus of the hippocampus in both AD and WT mice27. AD mice showed a reduced population of neurovascular-associated astrocytes compared with WT mice. Exercise training reversed this reduction and was accompanied by an increase in disease-associated microglia. Analysis of apoptotic markers suggested that exercise training mitigates AD-related neuronal cell death in the hippocampus, perhaps by regulating the NF-κB-Bax-Bcl-2-caspase pathway. In agreement with our findings, previous studies showed that exercise training mitigates neuronal apoptosis by modulating the NF-κB-Bax-Bcl-2-caspase pathway in AD models28,29. Collectively, findings from the current and previous studies suggest that exercise training mitigates neuroinflammation, myelin damage, and neuronal cell death due to AD. The exercise training-induced benefits of anti-inflammation and cell survival for AD may be linked to modulation of the BDNF-TrkB-PI3K-Akt pathway and its downstream signaling pathway, particularly the NF-κB-Bax-Bcl-2-caspase pathway30. Our study had several limitations. First, we focused only on protein levels. Previous studies showed that muscle contraction releases various myokines at the mRNA and protein level, which may travel to the brain and influence mitochondrial and cellular functions31. Second, caution is necessary when interpreting the role of the BDNF-TrkB pathway, as our study did not include any functional verification experiments to confirm its causal involvement in exercise training-induced benefits for AD. Additionally, exercise training-induced myokines and other neurotrophic factors may also be involved in its beneficial effects on AD pathology32. Third, although we observed significant effects of exercise training, its overall impact on mitochondrial activity requires further validation. Previous research linked PGC-1α deficiency and overexpression to alterations in mitochondrial gene expression, which plays a crucial role in neural development and function33. Fourth, our study focused on the hippocampus, a region associated with learning and memory, while other brain areas were not investigated. Consequently, it is uncertain whether the identified exercise-induced benefits are specific to the hippocampus or indicative of more extensive pleiotropic effects, underscoring the necessity for forthcoming studies to evaluate multiple brain regions. Fifth, the resolution of the microscopic images used in this study was insufficient to detect detailed structural changes. Future research should utilize advanced imaging techniques, such as transmission electron microscopy, to evaluate exercise-induced remyelination21. Finally, the cellular mechanisms underlying the effects of the exercise training observed require further investigation. Conclusions We examined the beneficial effects of exercise training on AD, focusing on AD neuropathology and cognitive impairment. We found that 20 weeks of treadmill running mitigated multiple aspects of AD neuropathology and resulted in full recovery from AD-like cognitive impairment in 3xTg-AD mice, supporting the therapeutic potential of physical exercise as an alternative to slow disease progression and to alleviate disease severity. Specifically, the observed effects of exercise training, initiated at 4 months of age, when early AD pathology is already evident10,11, may indicate that exercise training possesses both preventive and therapeutic effects on the disease pathology. Finally, although caution is warranted, we speculate that the study findings suggest that the beneficial effects of exercise training on AD may be linked to modulation of the BDNF-TrkB signaling complex and its downstream targets. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 1 Supplementary Material 2 Supplementary Material 3